president Francisco Sagasti Announcing the signing of an agreement with Chinese pharmaceutical company Sinopharm for the supply of 38 million doses. Vaccine Against COVID-19 In a message to the nation, the president announced that the first million vaccines will arrive in January. Two times required
Read Also
- Mediapro will broadcast the League 1 with Netflix – Presse-citron Jul 30, 2020
- Shang-Chi and the Legend of the Ten Rings: here are the comics to read first Sep 1, 2021
- The government will pay S / 94 million for the first Sinopharm vaccine, declaring MEF. [VIDEO] – Commerce Peru Jan 12, 2021
- Edson Dávila ‘Giselo’ celebrated five years of relationship with his partner: “Let there be many more” Oct 10, 2021
- Dominican Hands: A New Home for Artisans May 30, 2022
- Barbra Streisand gave the daughter of George Floyd shares Disney Jun 15, 2020
- Niece Rotaru showed how she spends honeymoon Jun 17, 2020
This is the first agreement the Peruvian state has signed with a pharmaceutical company for the purchase of the vaccine.
Sinopharm vaccine is 79% effective and is “Conditional” for marketing from the Chinese health agency, Sinopharm is the first Chinese pharmaceutical group to report data on the effectiveness of vaccines in their preparations.
United Arab Emirates and Egypt It is the other two countries that have announced they have approved a vaccine made by Sinopharm with the Beijing Institute of Biological Products.
The efficacy rate of Sinopharm’s vaccine is lower than what competitors Pfizer / BioNTech (95%) and Moderna claim (94.1%).
Peru is part of the Phase III clinical trial of the Sinopharm vaccine. Thousands of people volunteer and receive both of these vaccines under the supervision of the Sinopharm. Cayetano Heredia Peruvian University (UPCH) and National University of San Marcos (UNMSM)
